89bio, Inc.
ETNB
$8.45
$0.273.30%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -194.16% | -329.30% | -24.95% | -79.22% | -63.54% |
| Total Depreciation and Amortization | -43.75% | -20.00% | 20.00% | -35.71% | 6.67% |
| Total Amortization of Deferred Charges | 82.12% | -26.78% | -29.11% | -26.03% | -66.67% |
| Total Other Non-Cash Items | 44.02% | 88.12% | -5.18% | -37.47% | 41.63% |
| Change in Net Operating Assets | -301.11% | -145.64% | -2,532.19% | 280.06% | 173.26% |
| Cash from Operations | -254.53% | -378.77% | -77.56% | -32.03% | -26.56% |
| Capital Expenditure | -275.00% | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.17% | -122.54% | 127.35% | -2,045.88% | -475.45% |
| Cash from Investing | 131.15% | -122.54% | 127.35% | -2,045.88% | -475.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -15.79% | 21,050.43% | -9.44% | -92.81% | 665.43% |
| Repurchase of Common Stock | -- | 43.39% | -- | -143.29% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.89% | 2,342.64% | -9.12% | -93.46% | 671.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.06% | -1,962.87% | 94.92% | -133.34% | 474.64% |
